Molecule of the month

Current Topics in Medicinal Chemistry

Volumn 8, Issue 12, 2008, Pages 1100-

  Lindsley, Craig W ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN; CETIRIZINE; CLOPIDOGREL; ESOMEPRAZOLE; ETANERCEPT; FLUTICASONE PROPIONATE PLUS SALMETEROL; GENERIC DRUG; LANSOPRAZOLE; MELOXICAM; MONTELUKAST; NEW DRUG; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROVOCHOL; QUETIAPINE; RECOMBINANT ERYTHROPOIETIN; SERTRALINE; SIMVASTATIN; UNCLASSIFIED DRUG; ZOLPIDEM TARTRATE;

DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; PATENT; POSTMARKETING SURVEILLANCE; PRESCRIPTION; REVIEW;

ANTILIPEMIC AGENTS; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIAS; MOLECULAR STRUCTURE; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 52949083561     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802608785161448     Document Type: Review

References (5)

1. Lamb, E. Top 200 prescription drugs of 2007. Pharmacy Times, May 2008, pp. 1-3, and reference therein.
2. Lamb, E. Top 200 prescription drugs of 2006. Pharmacy Times, May 2007, pp. 1-4, and reference therein.
3. IMS Health. Press release. March 12, 20018, www.imshealth.com.
4. For more information on generic drug approvals and impact on sales see the US Food and Drug Adminstration: www.fda.gov.
5. Bennett, J. Barron's Online. January 15, 2008, www.online.barrons.com/article/SB12003495592948561.html.